Zacks Investment Research on MSN
CHMP backs EU approval of MRNA's new COVID-19 vaccine mNexSpike
Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the EU approval of mNexspike ...
NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use previously issued a positive opinion ...
The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.
Moderna on Monday said that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the marketing authorization of mNexspike, a new Covid-19 vaccine. The committee's ...
Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna’s COVID-19 vaccines for the ...
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback